Bausch Health Companies (BHC) Assets Average (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Assets Average came in at $25.4 billion in Q1 2026, down 3.93% year-on-year from $26.5 billion in Q1 2025, and down 4.37% quarter-over-quarter from $26.6 billion in Q4 2025.
Bausch Health Companies (BHC) Assets Average (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Assets Average across 17 years of filings, most recently posting $25.4 billion for Q1 2026.
- Assets Average for Q1 2026 came in at $25.4 billion, down 3.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.4 billion (down 3.93% YoY), and the FY2025 annual result was $26.4 billion, down 1.83% from the prior year.
- Assets Average came in at $25.4 billion for Q1 2026 at Bausch Health Companies, down from $26.6 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $29.1 billion in Q1 2022 to a low of $25.4 billion in Q1 2026.
- The 5-year median for Assets Average is $26.6 billion (2025), against an average of $26.8 billion.
- Across the five-year window, Assets Average slipped 12.28% in 2023 and advanced 6.13% in 2024, its largest moves.
- Bausch Health Companies' Assets Average stood at $26.0 billion in 2022, then gained by 4.67% to $27.2 billion in 2023, then decreased by 2.48% to $26.5 billion in 2024, then gained by 0.24% to $26.6 billion in 2025, then slipped by 4.37% to $25.4 billion in 2026.
- The last three Assets Average figures came in at $25.4 billion (Q1 2026), $26.6 billion (Q4 2025), and $27.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 25.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.43 Bn |
| Dec 31, 2025 | 26.60 Bn |
| Sep 30, 2025 | 27.05 Bn |
| Jun 30, 2025 | 26.84 Bn |
| Mar 31, 2025 | 26.47 Bn |
| Dec 31, 2024 | 26.53 Bn |
| Sep 30, 2024 | 26.52 Bn |
| Jun 30, 2024 | 26.70 Bn |
| Mar 31, 2024 | 27.13 Bn |
| Dec 31, 2023 | 27.21 Bn |
| Sep 30, 2023 | 26.28 Bn |
| Jun 30, 2023 | 25.47 Bn |
| Mar 31, 2023 | 25.57 Bn |
| Dec 31, 2022 | 25.99 Bn |
| Sep 30, 2022 | 27.23 Bn |
| Jun 30, 2022 | 28.63 Bn |
| Mar 31, 2022 | 29.15 Bn |
| Dec 31, 2021 | 29.23 Bn |
| Sep 30, 2021 | 29.65 Bn |
| Jun 30, 2021 | 30.12 Bn |